Women expecting a baby or planning a pregnancy are being offered a fast-growing array of tests to check if they are carriers for hundreds of mostly rare genetic diseases, as reported in the January 6th issue of the Wall Street Journal.
Such genetic testing, called carrier screening, has long been targeted mainly at people of certain ethnic groups such as …
Doctors are devising new ways to shield patients from information about their odds for disease as genetic testing becomes more common in IVF.
Nondisclosure PGD is mainly associated with diseases for which there is no cure. When patients know there is a treatment, they tend to want information about whether their genetic makeup puts them at higher risk for a …
Preimplantation genetic diagnosis, known as PGD, has been used in conjunction with IVF for years to avoid having a child with a serious genetic disease such as cystic fibrosis, spinal muscular atropy and Tay-Sachs. Now, as reported in an article in the February 18 edition of the Wall Street Journal, its use is being extended to aviod transferring a …
Ar article in the February 4, 2014 edition of the New York Times outlines ethical questions facing couples who have a family history of a genetic disease and choose to have preimplantation genetic diagnosis (PGD) with transfer of unaffected embryos (non-carriers.
Genetic testing of embryos has been around for more than a decade, but its use has soared in recent …
Video interviews of Reproductive Partners’ doctors are now being featured on fertilityauthority.com.
Dr. Andy Huang discusses discusses the latest technique in egg freezing for fertility preservation: vitrification.
Dr Huang is interviewed on how vitrification is an effective and highly successful way of freezing eggs and embryos.
Dr. David Meldrum explains how lifestyle affects fertility.
Dr Arthur Wisot explains how …
This is one of a series of news items from abstracts of studies presented at the Annual Meeting of the American Society for Reproductive Medicine as complied by Dr. David Meldrum, Scientific Director of Reproductive Partners. We appreciate the enormous amount of work it takes to compile and comment on these abstracts.
The occurrence of a serious genetic disease …
This is one of a series of news items from abstracts of studies presented at the Annual Meeting of the American Society for Reproductive Medicine as complied by Dr. David Meldrum, Scientific Director of Reproductive Partners. We appreciate the enormous amount of work it takes to compile and comment on these abstracts.
In a study reported at ASRM the two …
A study presented at the American Society of Reproductive Medicine Conference in Orlando last week, aimed to compare the safety and efficacy of embryo biopsies conducted for the purposes of screening for genetic disease at day 3 (cleavage stage) versus day 5 (blastocyst stage) of embryonic development. The impact that biopsy has on an embryo's ability to implant and develop …
An interesting question on the Reproductive Partners Fertility Forum about possiblility of doing preimpantation geneic screening for chromosomes (PGS) on frozen blastocysts raises some important points.
Q. I currently have frozen embryo's in La Jolla, we have a 17 month old son and are now starting to discuss a second child. My question is if CGH can be perfomed on …
According to a survey of 26 sperm banks reported in the July 2010 edition of Fertility and Sterility, sperm banks vary considerably in their practices of genetic screening of donors.
Cystic fibrosis carrier screening, chromosome analyses, and hemoglobin evaluations are performed on the majority of sperm donor applicants. Tay-Sachs disease carrier screening is performed on most donors with Jewish heritage but …